Related Experiment Video
Updated: Feb 10, 2026

Green Fluorescent Protein-based Expression Screening of Membrane Proteins in Escherichia coli
Published on: January 6, 2015
Clinically relevant mutations in the ABCG2 transporter uncovered by genetic analysis linked to erythrocyte membrane
Boglárka Zámbó1, Zsuzsa Bartos1, Orsolya Mózner1
1Institute of Enzymology, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Magyar Tudosok krt. 2, Budapest, 1117, Hungary.
Abstract:
The ABCG2 membrane protein is a key xeno- and endobiotic transporter, modulating the absorption and metabolism of pharmacological agents and causing multidrug resistance in cancer. ABCG2 is also involved in uric acid elimination and its impaired function is causative in gout. Analysis of ABCG2 expression in the erythrocyte membranes of healthy volunteers and gout patients showed an enrichment of lower expression levels in the patients. By genetic screening based on protein expression, we found a relatively frequent, novel ABCG2 mutation (ABCG2-M71V), which, according to cellular expression studies, causes reduced protein expression, although with preserved transporter capability. Molecular dynamics simulations indicated a stumbled dynamics of the mutant protein, while ABCG2-M71V expression in vitro could be corrected by therapeutically relevant small molecules. These results suggest that personalized medicine should consider this newly discovered ABCG2 mutation, and genetic analysis linked to protein expression provides a new tool to uncover clinically important mutations in membrane proteins.
Insights
A novel ABCG2 mutation (ABCG2-M71V) reduces transporter protein expression, impacting gout and drug resistance. This discovery highlights the need for personalized medicine considering genetic variations in membrane proteins.
Area of Science:
- Biochemistry and Molecular Biology
- Pharmacogenomics
- Membrane Transport Proteins
Background:
- The ATP-binding cassette subfamily G member 2 (ABCG2) is a crucial transporter protein involved in xenobiotic and endobiotic transport.
- ABCG2 dysfunction is implicated in conditions such as gout and multidrug resistance in cancer.
- Reduced ABCG2 expression has been observed in erythrocyte membranes of gout patients.
Purpose of the Study:
- To identify novel mutations in ABCG2 associated with altered protein expression.
- To investigate the functional consequences of identified mutations on ABCG2 transport activity.
- To explore potential therapeutic strategies for ABCG2-related disorders.
Main Methods:
- Analysis of ABCG2 expression in erythrocyte membranes from healthy volunteers and gout patients.
- Genetic screening to identify ABCG2 mutations based on protein expression levels.
- In vitro cellular expression studies to assess the impact of mutations on protein expression and function.
- Molecular dynamics simulations to elucidate the structural and dynamic effects of mutations.
- Testing of small molecules for their ability to correct mutant ABCG2 expression.
Main Results:
- A novel, relatively frequent ABCG2 mutation, ABCG2-M71V, was identified.
- Cellular expression studies revealed that ABCG2-M71V leads to reduced protein expression but retains transporter capability.
- Molecular dynamics simulations suggested altered protein dynamics for the ABCG2-M71V mutant.
- Therapeutically relevant small molecules demonstrated the ability to correct ABCG2-M71V expression in vitro.
Conclusions:
- The ABCG2-M71V mutation is a significant finding with implications for gout and cancer treatment.
- Genetic analysis combined with protein expression profiling is a valuable approach for discovering clinically relevant membrane protein mutations.
- Personalized medicine strategies should incorporate the identification of specific ABCG2 mutations for tailored therapeutic interventions.
More Related Videos
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
13:16Characterization of Membrane Transporters by Heterologous Expression in E. coli and Production of Membrane Vesicles
Published on: December 31, 2019
Related Concept Videos
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Mutation, Gene Flow, and Genetic Drift
Protein Transport to the Inner Chloroplast Membrane
Protein Transport into the Inner Mitochondrial Membrane
Transport of mitochondrial precursors across the TIM23 channel is driven by...
Introduction to Membrane Proteins
Protein Transport to the Outer Chloroplast Membrane
Two models describe the mechanism of precursor recognition and entry across the outer membrane through the TOC complex. Model 1 suggests the newly synthesized precursor binds to the TOC receptor 159 and forms a complex.